| Literature DB >> 35075424 |
Joanna Podgórska1, Katarzyna Pasicz2, Witold Skrzyński2, Bogumił Gołębiewski1, Piotr Kuś1, Jakub Jasieniak1, Anna Kiliszczyk3, Agnieszka Rogowska4,5, Thomas Benkert6, Jakub Pałucki1, Iwona Grabska2, Ewa Fabiszewska2, Beata Jagielska3, Paweł Kukołowicz2, Andrzej Cieszanowski1,7.
Abstract
INTRODUCTION: In order to improve the efficacy of intravoxel incoherent motion (IVIM) parameters in characterising specific tissues, a new concept is introduced: the perfusion-diffusion ratio (PDR), which expresses the relationship between the signal S(b) decline rate as a result of IVIM and the rate of signal S(b) decline due to diffusion. The aim of this study was to investigate this novel approach in the differentiation of solid primary liver lesions. Material and Methods. Eighty-three patients referred for liver MRI between August 2017 and January 2020 with a suspected liver tumour were prospectively examined with the standard liver MRI protocol extended by DWI-IVIM sequence. Patients with no liver lesions, haemangiomas, or metastases were excluded. The final study population consisted of 34 patients with primary solid liver masses, 9 with FNH, 4 with regenerative nodules, 10 with HCC, and 11 with CCC. The PDR coefficient was introduced, defined as the ratio of the rate of signal S(b) decrease due to the IVIM effect to the rate of signal S(b) decrease due to the diffusion process, for b = 0.Entities:
Mesh:
Year: 2022 PMID: 35075424 PMCID: PMC8783718 DOI: 10.1155/2022/2957759
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Study population flowchart.
Figure 2An FNH lesion is shown. Images (a–j) represent subsequent b-values in IVIM acquisition; image (k) is T2 haste FS and shows mild hyperintensity of the lesion with a greater signal in the central scar; (l–o) are arterial, portal venous, and equilibrium phase after Gd-Bopta administration and present homogeneous arterial enhancement, with no washout; (p) is the hepatobiliary phase which shows enhancement of the lesion greater compared to the surrounding liver.
Figure 3An HCC lesion is shown. Images (a–j) represent subsequent b-values in IVIM acquisition; image (k) is T2 haste FS and shows mild hyperintensity of the lesion; (l-o) are arterial, portal venous, and equilibrium phase after Gd-Bopta administration and present arterial enhancement, with washout and capsule appearance; (p) is the hepatobiliary phase which shows enhancement of the lesion similar compared to the surrounding liver.
Acquisition parameters of liver MRI parameters (except for the DWI sequence).
| Sequence | Plane | TR | TE | Slice thickness | Breath |
|---|---|---|---|---|---|
| Trufi | Coronal | 505 | 1.7 | 5.0 | BH |
| T2 Haste FS | Coronal | 1220 | 103 | 5.0 | MBH |
| T2 Haste | Axial | 1600 | 91 | 5.0 | MBH |
| T2 Haste | Axial | 1600 | 201 | 5.0 | MBH |
| T2 Blade FS | Axial | 6687 | 90 | 5.0 | RT |
| T2 Haste FS | Axial | 1900 | 91 | 5.0 | MBH |
| VIBE Dixon | Axial | 3.3 | 1.3 | 3.0 | BH |
| TWIST VIBE Dixon + C | Axial | 3.9 | 2.5 | 3.0 | BH |
| TWIST VIBE Dixon + C | Coronal | 4.2 | 2.6 | 1.5 | BH |
FS: fat suppressed; TR: repetition time; TE: echo time; BH: breath hold; MBH: multibreath hold; RT: respiratory triggered; +C: contrast enhanced.
Detailed acquisition parameters of the IVIM-DWI sequence.
| Acquisition parameters | |
|---|---|
| TR | 6100 ms |
| TE | 56 ms |
| Slice thickness | 5 mm |
| Number of slices | 33 |
| Filter | Moderate |
| Bandwidth | 2298 Hz/px |
|
| 0, 10, 30, 50, 75, 100, 150, 200, 500, 900 |
| NSA | 3-6 |
| Breath | Free |
ADC and IVIM-derived including PDR in the differentiation of benign and malignant liver lesions (median ± the standard deviation).
| Parameter | Benign | Malignant |
|
|---|---|---|---|
|
| 0.17 ± 0.16 | 0.15 ± 0.22 | 0.80 |
|
| 0.98 ± 0.54 | 1.06 ± 0.36 | 0.35 |
|
| 38 ± 48 | 26 ± 39 | 0.22 |
| PDR | 10.1 ± 7.3 | 4.4 ± 4.3 | 0.03 |
| ADC0-500-900 | 1.20 ± 0.58 | 1.28 ± 0.38 | 0.90 |
Figure 4Box-and-whisker plots illustrate the median, interquartile range, minimum, maximum, and outlier data for all measured lesions: (a) f, (b) D, (c) D∗, (d) perfusion-diffusion ratio (PDR), and (e) ADC (0, 500, and 900). Significant differences between benign and malignant lesions were only observed for the PDR parameter.
Figure 5Receiver operating characteristic (ROC) curve for differentiation between benign and malignant liver lesions using the PDR parameter.